Symptom (continuous) | Mean value in patients with progressive loss (n) | Mean value in patients without progressive visual loss (n) | t test p value | OR | 95% CI |
CRP on presentation | 57.43 (7) | 22.17 (12) | 0.016 | ||
Age (y) | 79.41 (14) | 73.7 (76) | 0.042 | 1.1147 | 1.0208–1.2171 |
Glucose (mg/dl) | 155.8 (14) | 154.5 (67) | 0.297 | 1.0699 | 0.9009–1.2707 |
Diastolic BP (mm Hg) | 86.79 (14) | 82.25 (76) | 0.066 | 1.0371 | 0.9839–1.0932 |
Systolic BP (mm Hg) | 159.64 (14) | 152.15 (76) | 0.305 | 1.0118 | 0.9894–1.0347 |
ESR at referral (mm/h) | 77.92 (13) | 71.90 (59) | 0.466 | 1.01 | 0.99–1.03 |
Time referral to admission (days) | 18.29 (14) | 6.18 (71) | 0.497 | 1.0093 | 0.9941–1.0247 |
ESR at presentation (mm/h) | 70.79 (14) | 67.70 (76) | 0.671 | 1.0044 | 0.9830–1.0263 |
Platelets at presentation | 463.36 (11) | 453.79 (56) | 0.854 | 1.0004 | 0.9962–1.0047 |
Steroid dose (mg HC) | 780 (14) | 479.21 (76) | 0.437 | 1.0002 | 0.9998–1.0007 |
Onset of symptoms (days) | 109.36 (14) | 128.35 (75) | 0.681 | 0.9997 | 0.9975–1.0020 |
Length of hospital stay | 21.57 (14) | 9.13 (76) | 0.005 | 1.1044 | 1.0403–1.1725 |
BP, blood pressure; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; HC, hydrocortisone.
*Fisher’s exact test.